Esperion Therapeutics Statistics
Total Valuation
ESPR has a market cap or net worth of $626.62 million. The enterprise value is $1.01 billion.
Important Dates
The last earnings date was Tuesday, March 10, 2026, before market open.
| Earnings Date | Mar 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ESPR has 256.81 million shares outstanding. The number of shares has increased by 11.05% in one year.
| Current Share Class | 256.81M |
| Shares Outstanding | 256.81M |
| Shares Change (YoY) | +11.05% |
| Shares Change (QoQ) | +41.76% |
| Owned by Insiders (%) | 0.83% |
| Owned by Institutions (%) | 59.77% |
| Float | 254.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 183.05 |
| PS Ratio | 1.55 |
| Forward PS | 1.49 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.50 |
| EV / EBITDA | 16.67 |
| EV / EBIT | 16.70 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.54
| Current Ratio | 1.54 |
| Quick Ratio | 1.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | 8.70 |
| Debt / FCF | n/a |
| Interest Coverage | 0.71 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 9.30% |
| Return on Invested Capital (ROIC) | 16.80% |
| Return on Capital Employed (ROCE) | 36.51% |
| Weighted Average Cost of Capital (WACC) | 11.21% |
| Revenue Per Employee | $1.37M |
| Profits Per Employee | -$77,150 |
| Employee Count | 294 |
| Asset Turnover | 1.00 |
| Inventory Turnover | 1.39 |
Taxes
In the past 12 months, ESPR has paid $1.84 million in taxes.
| Income Tax | 1.84M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +60.53% in the last 52 weeks. The beta is 1.11, so ESPR's price volatility has been higher than the market average.
| Beta (5Y) | 1.11 |
| 52-Week Price Change | +60.53% |
| 50-Day Moving Average | 3.30 |
| 200-Day Moving Average | 2.58 |
| Relative Strength Index (RSI) | 29.52 |
| Average Volume (20 Days) | 4,830,292 |
Short Selling Information
The latest short interest is 33.53 million, so 13.05% of the outstanding shares have been sold short.
| Short Interest | 33.53M |
| Short Previous Month | 33.57M |
| Short % of Shares Out | 13.05% |
| Short % of Float | 13.16% |
| Short Ratio (days to cover) | 9.59 |
Income Statement
In the last 12 months, ESPR had revenue of $403.14 million and -$22.68 million in losses. Loss per share was -$0.11.
| Revenue | 403.14M |
| Gross Profit | 226.06M |
| Operating Income | 60.27M |
| Pretax Income | -20.84M |
| Net Income | -22.68M |
| EBITDA | 60.38M |
| EBIT | 60.27M |
| Loss Per Share | -$0.11 |
Full Income StatementBalance Sheet
The company has $167.85 million in cash and $548.00 million in debt, with a net cash position of -$380.15 million or -$1.48 per share.
| Cash & Cash Equivalents | 167.85M |
| Total Debt | 548.00M |
| Net Cash | -380.15M |
| Net Cash Per Share | -$1.48 |
| Equity (Book Value) | -301.97M |
| Book Value Per Share | -1.23 |
| Working Capital | 161.76M |
Full Balance SheetCash Flow
| Operating Cash Flow | -13.09M |
| Capital Expenditures | n/a |
| Free Cash Flow | -13.09M |
| FCF Per Share | -$0.05 |
Full Cash Flow StatementMargins
Gross margin is 56.08%, with operating and profit margins of 14.95% and -5.63%.
| Gross Margin | 56.08% |
| Operating Margin | 14.95% |
| Pretax Margin | -5.17% |
| Profit Margin | -5.63% |
| EBITDA Margin | 14.98% |
| EBIT Margin | 14.95% |
| FCF Margin | n/a |
Dividends & Yields
ESPR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.05% |
| Shareholder Yield | -11.05% |
| Earnings Yield | -3.62% |
| FCF Yield | -2.09% |
Analyst Forecast
The average price target for ESPR is $7.60, which is 211.48% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.60 |
| Price Target Difference | 211.48% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 24.85% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ESPR has an Altman Z-Score of -2.84 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.84 |
| Piotroski F-Score | 4 |
